The EMA schedule meetings for review of products on a monthly basis, much like the RBA board schedules their interest rate reviews. It's a panel of people that may have to come from all over Europe to conduct this meeting.
If they brought forward the process it wouldn't be fair to other companies that are having their products reviewed in the same period. I know, TIS has been dicked around by EMA with scheduling, but it's not a two way street with these sort of organisations.
TIS Price at posting:
22.5¢ Sentiment: Buy Disclosure: Held
